Our Organization’s Perspective on the Safety of NMN Intravenous Therapy

Our company began selling NMN research reagents in 2021, and we are currently supplying them to over 300 medical institutions. Many patients have used our NMN research reagents through these medical institutions, and to date, there have been no reports of serious side effects.

There have been some reports suggesting that NMN intravenous administration destroys NAD or causes neurological disorders such as ALS, but there is no evidence or case reports to support these claims.

Additionally, Professor Samuel Klein from the Washington University School of Medicine, who is well-acquainted with our company, has provided the following message regarding the safety of NMN intravenous therapy:

Excerpt: “I am not aware of any data that showed NMN infusion destroys NAD and have not seen any data showing any serious side effects of NMN.

I would be excited to do a study evaluating the safety and efficacy of intravenous NMN and this could be done before we finish the current oral dosing study.”

Moving forward, our company remains committed to disseminating accurate information about NMN intravenous therapy and providing high-quality NMN research reagents that can be used with confidence.